Clinical trial for pre-exposure prophylaxis for HIV infection toward Tokyo Olympic
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Aug 2019
Price : $35 *
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 03 Aug 2019 Status changed from recruiting to active, no longer recruiting.
- 15 Mar 2018 Status changed from not yet recruiting to recruiting.
- 30 Jan 2018 New trial record